SheMed UK

We have some news we're incredibly proud to share. Our co-founders, Olivia Ferro and Chloe Ferro, have been named in Forbes 30 Under 30 Europe in the Science & Healthcare category. When we started SheMed, we did so because we believed that women deserved better. Better access, better information, better care. That belief hasn't changed. If anything, every conversation we've had, every person we've reached, has only made it stronger. This recognition means a great deal to us, but what it means most is momentum. Momentum for the mission: closing the women's health gap, breaking down the barriers that have kept personalised healthcare out of reach for so many, and continuing to educate and empower people on what modern, tailored telehealth solutions can genuinely offer. To our community, our team, and everyone who has supported SheMed from the beginning – thank you. You are as much a part of this as we are. This is a milestone. It's not the destination. There's so much more work to do, and we couldn't be more energised to do it. forbes.com/sites/alexknap…

PCOS has officially been renamed PMOS — Polyendocrine Metabolic Ovarian Syndrome. After 11 years and input from 22,000+ people, the new name finally reflects what this condition actually is. A huge step forward for women's health. 📄thelancet.com/journals/lance…

Happy International Nurses Day 💕To our incredible clinical team at SheMed and to every nurse who's dedicated their life to caring for others – thank you. The work you do changes lives. #InternationalNursesDay #SheMed #ThankYouNurses

GLP-1 medications work by mimicking a natural hormone that helps regulate appetite, slow digestion, and support blood sugar control, which can lead to reduced hunger and more stable eating patterns. They’re not a shortcut, but a tool used alongside lifestyle support. 📚 Source: NICE (2023); Wilding et al., NEJM (2021)

Women’s bodies aren’t smaller versions of men’s. Hormones, menstrual cycles, perimenopause, stress – they all affect weight. That’s why women deserve weight care designed for them. Not adapted. Designed. 🌸 #SheMed #WomensHealthMatters

GLP-1s help regulate appetite – they don’t replace healthy habits. Long-term success comes from science + structure + support. Shortcut culture isn’t healthcare.

Not all GLP-1 programmes are created equal. Women’s bodies, hormones, and life stages matter – and should never be an afterthought. That’s why SheMed exists.

Weight loss meds don’t work in isolation. That’s why SheMed programmes are built around: • GLP-1 medication • Hormone-aware care • Ongoing clinician support Real results need real support.

GLP-1s aren’t a “trend” – they’re one of the most researched obesity treatments in history. At SheMed, we combine them with clinical oversight, nutrition, and women-specific care. Because safety always comes first 🤍

GLP-1s don’t just support weight loss – they act on appetite regulation, insulin sensitivity, and cardiometabolic risk. Large trials show meaningful weight reduction with appropriate dosing and monitoring – especially important for women. Evidence: thelancet.com/journals/landi…

This year, put yourself first 💗 Our New Year offer is live – £64 off 2 orders, personalised care, blood test included. Plans start from £75. Start your journey today → shemed.co.uk

✨ The SheMed Wellness Advent Calendar is officially open! ✨ We’re starting the season of self-care with a chance to win a £100 Amazon Gift Voucher – the perfect boost for your wellness journey. 💖 Head to our Instagram to take part and open today’s door: instagram.com/shemed_uk/ @SheMed_UK 24 days. 24 moments of care. 24 chances to put you first. #SheMed #WomenSupportingWomen #WellnessAdventCalendar

Novo Nordisk's Wegovy® (semaglutide 2.4 mg) was associated with liver health-related benefits not solely based on weight loss ... Read the full press release here: prn.to/4441v75

Still have questions about GLP-1s? Let’s talk about them - openly and honestly. Join the SheMed clinical team live on Sunday, 10th November at 7:30pm for a 30-minute GLP-1 FAQ webinar for anyone considering a GLP-1 programme. We’ll cover: ✅ How GLP-1s work and who they’re for ✅ Common misconceptions and safety considerations ✅ What makes SheMed the UK’s only women-focused GLP-1 programme This is your opportunity to hear directly from our experts, gain clarity, and ask your questions in a supportive, science-led environment. Register via the link below: lnkd.in/gh3VMK-N Ask your questions ahead of time: lnkd.in/gJXebXCU — SheMed Science. Safety. Support — for every woman’s journey. #SheMed #GLP1 #WomenInHealth #WomensHealth #WeightManagement #HealthInnovation #GLP1Journey #SheMedCommunity

Your health is an investment, not a gamble. That’s why SheMed puts safety first: - Medical oversight - Data-led results - Women-only care Trust, without compromise.

Hormones. Sleep. Stress. Weight loss is never just about food. We look at the whole picture - because you’re not a number, you’re a woman with a story.

The future of women’s health isn’t about shortcuts. It’s about listening, data, and personalisation. SheMed is building that future - starting with weight loss, and beyond.

Community isn’t a buzzword - it’s our foundation. Over 50,000 women, one supportive space. Because the journey feels lighter when you don’t walk it alone.

Let’s be clear: ❌ No fad diets ❌ No hidden fees ❌ No quick fixes ✅ Just science, safety, and support. That’s the SheMed promise.